Is Buprenorphine Effective for Chronic Pain? A Systematic Review and Meta-analysis

被引:29
作者
Lazaridou, Asimina [1 ]
Paschali, Myrella [1 ]
Edwards, Robert R. [1 ]
Gilligan, Christopher [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol, Chestnut Hill, MA USA
关键词
Buprenorphine; Chronic Pain; Opioid Use Disorder; LOW-BACK-PAIN; TRANSDERMAL BUPRENORPHINE; BUCCAL BUPRENORPHINE; ANALGESIC EFFICACY; OPEN-LABEL; MODERATE; TOLERABILITY; OUTCOMES; OPIOIDS; SAFETY;
D O I
10.1093/pm/pnaa089
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. The objective was to perform a systematic review and meta-analysis of the literature on the effects of buprenorphine on chronic pain outcomes (i.e., patient-reported pain intensity) in patients with and without opioid use disorder (OUD). Design. Ovid/Medline, PubMed, Embase, and the Cochrane Library were searched for studies that explored the effectiveness (in reducing pain) of buprenorphine treatment for chronic pain patients with and without a history of OUD. Randomized controlled trials and observational studies were included in the review. Methods. Two separate searches were conducted to identify buprenorphine trials that included chronic pain patients either with or without OUD. Five studies used validated pain report measures and included a chronic pain population with OUD. Nine studies used validated report measures and included chronic pain patients without OUD. Meta-analysis was performed using the R, version 3.2.2, Metafor package, version 1.9-7. Results. The meta-analysis revealed that buprenorphine has a beneficial effect on pain intensity overall, with a small mean effect size in patients with comorbid chronic pain and OUD and a moderate- to large-sized effect in chronic pain patients without OUD. Conclusions. Our results indicate that buprenorphine is modestly beneficial in reducing pain intensity in patients without OUD. Although informative, these findings should be carefully interpreted due to the small amount of data available and the variation in study designs.
引用
收藏
页码:3691 / 3699
页数:9
相关论文
共 47 条
[1]   Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients [J].
Baker, JR ;
Best, AM ;
Pade, PA ;
McCance-Katz, EF .
ANNALS OF PHARMACOTHERAPY, 2006, 40 (03) :392-396
[2]   Refractory dependence on opioid analgesics [J].
Ballantyne, Jane C. ;
Sullivan, Mark D. ;
Koob, George F. .
PAIN, 2019, 160 (12) :2655-2660
[3]   Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics [J].
Bazov, Igor ;
Sarkisyan, Daniil ;
Kononenko, Olga ;
Watanabe, Hiroyuki ;
Yakovleva, Tatiana ;
Hansson, Anita C. ;
Sommer, Wolfgang H. ;
Spanagel, Rainer ;
Bakalkin, Georgy .
MOLECULAR NEUROBIOLOGY, 2018, 55 (08) :7049-7061
[4]   Development of κ Opioid Receptor Antagonists [J].
Carroll, F. Ivy ;
Carlezon, William A., Jr. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (06) :2178-2195
[5]   Buprenorphine-Naloxone Therapy in Pain Management [J].
Chen, Kelly Yan ;
Chen, Lucy ;
Mao, Jianren .
ANESTHESIOLOGY, 2014, 120 (05) :1262-1274
[6]  
Chou Roger, 2014, Evid Rep Technol Assess (Full Rep), P1, DOI 10.23970/AHRQEPCERTA218
[7]   No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters [J].
D'Elia, M ;
Patenaude, J ;
Hamelin, C ;
Garrel, DR ;
Bernier, J .
CLINICAL IMMUNOLOGY, 2003, 109 (02) :179-187
[8]   Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients [J].
Dagtekin, Oguzhan ;
Gerbershagen, Hans J. ;
Wagner, Werner ;
Petzke, Frank ;
Radbruch, Lukas ;
Sabatowski, Rainer .
ANESTHESIA AND ANALGESIA, 2007, 105 (05) :1442-1448
[9]   Buprenorphine induces ceiling in respiratory depression but not in analgesia [J].
Dahan, A ;
Yassen, A ;
Romberg, R ;
Sarton, E ;
Teppema, L ;
Olofsen, E ;
Danhof, M .
BRITISH JOURNAL OF ANAESTHESIA, 2006, 96 (05) :627-632
[10]  
Davis Mellar P, 2012, J Support Oncol, V10, P209, DOI 10.1016/j.suponc.2012.05.002